Please Wait.....
Report
Monkeypox Vaccine and Treatment Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2030
Market Report I 2024-02-28 I 300 Pages I Infinium Global Research and Consulting Solutions
The report on the global monkeypox vaccine and treatment market provides qualitative and quantitative analysis for the period from 2021-2030. The global monkeypox vaccine and treatment market was valued at USD 8.19 billion in 2022 and is expected to reach USD 19.68 billion in 2030, with a CAGR of 10.14% during the forecast period 2023-2030. The study on monkeypox vaccine and treatment market covers the analysis of the leading geographies such as North America, Europe, Asia Pacific, and RoW for the period of 2021-2030.
The monkeypox vaccine and treatment market refer to the commercial landscape associated with products and services aimed at preventing and managing monkeypox infections. This includes the development, production, and distribution of vaccines and treatments designed to mitigate the impact of monkeypox outbreaks. Companies operating in this market focus on research, manufacturing, and strategic partnerships to provide effective solutions, addressing the demand for medical interventions in regions susceptible to monkeypox infections. The market plays a crucial role in public health by offering preventive measures and therapeutic options for individuals and communities affected by monkeypox. The increasing incidence of monkeypox, accompanied by intermittent outbreaks, serves as a notable catalyst for the market. This heightened prevalence has created a demand for effective solutions and therapeutics, driving growth and innovation within the industry. As stakeholders seek to address the challenges posed by these outbreaks, opportunities for research, development, and market expansion are on the rise. The urgency to combat and manage monkeypox has propelled investment and initiatives, positioning the market to play a pivotal role in public health and safety.
The injectables segment stands out as the fastest-growing category in the monkeypox vaccine and treatment market. This notable growth is attributed to various factors such as the efficacy and rapid response associated with injectable formulations. As the demand for effective monkeypox prevention and treatment options rises, the injectables segment gains prominence due to its convenience, efficiency, and potential for widespread application. This trend underscores the increasing importance of injectable solutions in addressing the challenges posed by monkeypox, contributing significantly to the overall expansion and advancement of the market.
North America is poised to hold the most prominent market share. This prominence can be attributed to the region's robust healthcare infrastructure, advanced research capabilities, and strategic investments in the field of infectious disease management. The heightened awareness and proactive approach of North American healthcare authorities in addressing emerging health threats further contribute to this dominance. Additionally, collaborations between pharmaceutical companies, research institutions, and government agencies in North America are fostering innovation and accelerating the development of effective monkeypox vaccines and treatments. The region's pivotal market position signifies lucrative opportunities for industry players and underscores its commitment to tackling public health challenges with cutting-edge solutions.
Report Findings
1) Drivers
- The rising prevalence of monkeypox, coupled with sporadic outbreaks, is a significant driver for the market.
- Growing awareness and emphasis on global health security and preparedness contribute to the market's momentum.
2) Restraints
- Stringent regulatory frameworks and meeting compliance standards can act as a barrier to market growth.
3) Opportunities
- Increasing research and development efforts aimed at developing effective monkeypox vaccines and treatments present a significant opportunity.
Research Methodology
A) Primary Research
Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include
1. Key Opinion Leaders associated with Infinium Global Research
2. Internal and External subject matter experts
3. Professionals and participants from the industry
Our primary research respondents typically include
1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.
B) Secondary Research
Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. At Infinium Global Research, each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.
The secondary sources of the data typically include
1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies
Segment Covered
The global monkeypox vaccine and treatment market is segmented on the basis of product, gender, route of administration, and end-use.
The Global Monkeypox Vaccine and Treatment Market by Product
- Vaccine
- Drugs
- Vaccinia Immune Globulin (VIG)
The Global Monkeypox Vaccine and Treatment Market by Gender
- Male
- Female
- Others
The Global Monkeypox Vaccine and Treatment Market by Route of Administration
- Oral
- Injectables
The Global Monkeypox Vaccine and Treatment Market by End-use
- Hospitals
- Speciality Clinics
- Others
Company Profiles
The companies covered in the report include
- Bavarian Nordic
- SIGA Technologies
- Chimerix, Inc.
- Piramal Pharma Solutions
- Gilead Sciences, Inc.
- Elabscience Biotechnology Inc.
- Goldsite Diagnostics Inc.
- Emergex Vaccines
- Emergent BioSolutions
- Emcure Pharmaceuticals
What does this Report Deliver?
1. Comprehensive analysis of the global as well as regional markets of the monkeypox vaccine and treatment market.
2. Complete coverage of all the segments in the monkeypox vaccine and treatment market to analyze the trends, developments in the global market and forecast of market size up to 2030.
3. Comprehensive analysis of the companies operating in the global monkeypox vaccine and treatment market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. IGR- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
Table of Content
Chapter 1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
Chapter 2. Executive Summary
2.1. Monkeypox Vaccine and Treatment Market Highlights
2.2. Monkeypox Vaccine and Treatment Market Projection
2.3. Monkeypox Vaccine and Treatment Market Regional Highlights
Chapter 3. Global Monkeypox Vaccine and Treatment Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter's Five Forces Analysis
3.4. IGR-Growth Matrix Analysis
3.4.1. IGR-Growth Matrix Analysis by Product
3.4.2. IGR-Growth Matrix Analysis by Gender
3.4.3. IGR-Growth Matrix Analysis by Route of Administration
3.4.4. IGR-Growth Matrix Analysis by End-use
3.4.5. IGR-Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Monkeypox Vaccine and Treatment Market
Chapter 4. Monkeypox Vaccine and Treatment Market Macro Indicator Analysis
Chapter 5. Company Profiles and Competitive Landscape
5.1. Competitive Landscape in the Global Monkeypox Vaccine and Treatment Market
5.2. Companies Profiles
5.2.1. Bavarian Nordic
5.2.2. SIGA Technologies
5.2.3. Chimerix, Inc.
5.2.4. Piramal Pharma Solutions
5.2.5. Gilead Sciences, Inc.
5.2.6. Elabscience Biotechnology Inc.
5.2.7. Goldsite Diagnostics Inc.
5.2.8. Emergex Vaccines
5.2.9. Emergent BioSolutions
5.2.10. Emcure Pharmaceuticals
Chapter 6. Global Monkeypox Vaccine and Treatment Market by Product
6.1. Vaccine
6.2. Drugs
6.3. Vaccinia Immune Globulin (VIG)
Chapter 7. Global Monkeypox Vaccine and Treatment Market by Gender
7.1. Male
7.2. Female
7.3. Others
Chapter 8. Global Monkeypox Vaccine and Treatment Market by Route of Administration
8.1. Oral
8.2. Injectables
Chapter 9. Global Monkeypox Vaccine and Treatment Market by End-use
9.1. Hospitals
9.2. Speciality Clinics
9.3. Others
Chapter 10. Global Monkeypox Vaccine and Treatment Market by Region 2023-2030
10.1. North America
10.1.1. North America Monkeypox Vaccine and Treatment Market by Product
10.1.2. North America Monkeypox Vaccine and Treatment Market by Gender
10.1.3. North America Monkeypox Vaccine and Treatment Market by Route of Administration
10.1.4. North America Monkeypox Vaccine and Treatment Market by End-use
10.1.5. North America Monkeypox Vaccine and Treatment Market by Country
10.1.5.1. The U.S. Monkeypox Vaccine and Treatment Market
10.1.5.1.1. The U.S. Monkeypox Vaccine and Treatment Market by Product
10.1.5.1.2. The U.S. Monkeypox Vaccine and Treatment Market by Gender
10.1.5.1.3. The U.S. Monkeypox Vaccine and Treatment Market by Route of Administration
10.1.5.1.4. The U.S. Monkeypox Vaccine and Treatment Market by End-use
10.1.5.2. Canada Monkeypox Vaccine and Treatment Market
10.1.5.2.1. Canada Monkeypox Vaccine and Treatment Market by Product
10.1.5.2.2. Canada Monkeypox Vaccine and Treatment Market by Gender
10.1.5.2.3. Canada Monkeypox Vaccine and Treatment Market by Route of Administration
10.1.5.2.4. Canada Monkeypox Vaccine and Treatment Market by End-use
10.1.5.3. Mexico Monkeypox Vaccine and Treatment Market
10.1.5.3.1. Mexico Monkeypox Vaccine and Treatment Market by Product
10.1.5.3.2. Mexico Monkeypox Vaccine and Treatment Market by Gender
10.1.5.3.3. Mexico Monkeypox Vaccine and Treatment Market by Route of Administration
10.1.5.3.4. Mexico Monkeypox Vaccine and Treatment Market by End-use
10.2. Europe
10.2.1. Europe Monkeypox Vaccine and Treatment Market by Product
10.2.2. Europe Monkeypox Vaccine and Treatment Market by Gender
10.2.3. Europe Monkeypox Vaccine and Treatment Market by Route of Administration
10.2.4. Europe Monkeypox Vaccine and Treatment Market by End-use
10.2.5. Europe Monkeypox Vaccine and Treatment Market by Country
10.2.5.1. Germany Monkeypox Vaccine and Treatment Market
10.2.5.1.1. Germany Monkeypox Vaccine and Treatment Market by Product
10.2.5.1.2. Germany Monkeypox Vaccine and Treatment Market by Gender
10.2.5.1.3. Germany Monkeypox Vaccine and Treatment Market by Route of Administration
10.2.5.1.4. Germany Monkeypox Vaccine and Treatment Market by End-use
10.2.5.2. United Kingdom Monkeypox Vaccine and Treatment Market
10.2.5.2.1. United Kingdom Monkeypox Vaccine and Treatment Market by Product
10.2.5.2.2. United Kingdom Monkeypox Vaccine and Treatment Market by Gender
10.2.5.2.3. United Kingdom Monkeypox Vaccine and Treatment Market by Route of Administration
10.2.5.2.4. United Kingdom Monkeypox Vaccine and Treatment Market by End-use
10.2.5.3. France Monkeypox Vaccine and Treatment Market
10.2.5.3.1. France Monkeypox Vaccine and Treatment Market by Product
10.2.5.3.2. France Monkeypox Vaccine and Treatment Market by Gender
10.2.5.3.3. France Monkeypox Vaccine and Treatment Market by Route of Administration
10.2.5.3.4. France Monkeypox Vaccine and Treatment Market by End-use
10.2.5.4. Italy Monkeypox Vaccine and Treatment Market
10.2.5.4.1. Italy Monkeypox Vaccine and Treatment Market by Product
10.2.5.4.2. Italy Monkeypox Vaccine and Treatment Market by Gender
10.2.5.4.3. Italy Monkeypox Vaccine and Treatment Market by Route of Administration
10.2.5.4.4. Italy Monkeypox Vaccine and Treatment Market by End-use
10.2.5.5. Rest of Europe Monkeypox Vaccine and Treatment Market
10.2.5.5.1. Rest of Europe Monkeypox Vaccine and Treatment Market by Product
10.2.5.5.2. Rest of Europe Monkeypox Vaccine and Treatment Market by Gender
10.2.5.5.3. Rest of Europe Monkeypox Vaccine and Treatment Market by Route of Administration
10.2.5.5.4. Rest of Europe Monkeypox Vaccine and Treatment Market by End-use
10.3. Asia Pacific
10.3.1. Asia Pacific Monkeypox Vaccine and Treatment Market by Product
10.3.2. Asia Pacific Monkeypox Vaccine and Treatment Market by Gender
10.3.3. Asia Pacific Monkeypox Vaccine and Treatment Market by Route of Administration
10.3.4. Asia Pacific Monkeypox Vaccine and Treatment Market by End-use
10.3.5. Asia Pacific Monkeypox Vaccine and Treatment Market by Country
10.3.5.1. China Monkeypox Vaccine and Treatment Market
10.3.5.1.1. China Monkeypox Vaccine and Treatment Market by Product
10.3.5.1.2. China Monkeypox Vaccine and Treatment Market by Gender
10.3.5.1.3. China Monkeypox Vaccine and Treatment Market by Route of Administration
10.3.5.1.4. China Monkeypox Vaccine and Treatment Market by End-use
10.3.5.2. Japan Monkeypox Vaccine and Treatment Market
10.3.5.2.1. Japan Monkeypox Vaccine and Treatment Market by Product
10.3.5.2.2. Japan Monkeypox Vaccine and Treatment Market by Gender
10.3.5.2.3. Japan Monkeypox Vaccine and Treatment Market by Route of Administration
10.3.5.2.4. Japan Monkeypox Vaccine and Treatment Market by End-use
10.3.5.3. India Monkeypox Vaccine and Treatment Market
10.3.5.3.1. India Monkeypox Vaccine and Treatment Market by Product
10.3.5.3.2. India Monkeypox Vaccine and Treatment Market by Gender
10.3.5.3.3. India Monkeypox Vaccine and Treatment Market by Route of Administration
10.3.5.3.4. India Monkeypox Vaccine and Treatment Market by End-use
10.3.5.4. South Korea Monkeypox Vaccine and Treatment Market
10.3.5.4.1. South Korea Monkeypox Vaccine and Treatment Market by Product
10.3.5.4.2. South Korea Monkeypox Vaccine and Treatment Market by Gender
10.3.5.4.3. South Korea Monkeypox Vaccine and Treatment Market by Route of Administration
10.3.5.4.4. South Korea Monkeypox Vaccine and Treatment Market by End-use
10.3.5.5. Australia Monkeypox Vaccine and Treatment Market
10.3.5.5.1. Australia Monkeypox Vaccine and Treatment Market by Product
10.3.5.5.2. Australia Monkeypox Vaccine and Treatment Market by Gender
10.3.5.5.3. Australia Monkeypox Vaccine and Treatment Market by Route of Administration
10.3.5.5.4. Australia Monkeypox Vaccine and Treatment Market by End-use
10.3.5.6. Rest of Asia-Pacific Monkeypox Vaccine and Treatment Market
10.3.5.6.1. Rest of Asia-Pacific Monkeypox Vaccine and Treatment Market by Product
10.3.5.6.2. Rest of Asia-Pacific Monkeypox Vaccine and Treatment Market by Gender
10.3.5.6.3. Rest of Asia-Pacific Monkeypox Vaccine and Treatment Market by Route of Administration
10.3.5.6.4. Rest of Asia-Pacific Monkeypox Vaccine and Treatment Market by End-use
10.4. RoW
10.4.1. RoW Monkeypox Vaccine and Treatment Market by Product
10.4.2. RoW Monkeypox Vaccine and Treatment Market by Gender
10.4.3. RoW Monkeypox Vaccine and Treatment Market by Route of Administration
10.4.4. RoW Monkeypox Vaccine and Treatment Market by End-use
10.4.5. RoW Monkeypox Vaccine and Treatment Market by Sub-region
10.4.5.1. Latin America Monkeypox Vaccine and Treatment Market
10.4.5.1.1. Latin America Monkeypox Vaccine and Treatment Market by Product
10.4.5.1.2. Latin America Monkeypox Vaccine and Treatment Market by Gender
10.4.5.1.3. Latin America Monkeypox Vaccine and Treatment Market by Route of Administration
10.4.5.1.4. Latin America Monkeypox Vaccine and Treatment Market by End-use
10.4.5.2. Middle East Monkeypox Vaccine and Treatment Market
10.4.5.2.1. Middle East Monkeypox Vaccine and Treatment Market by Product
10.4.5.2.2. Middle East Monkeypox Vaccine and Treatment Market by Gender
10.4.5.2.3. Middle East Monkeypox Vaccine and Treatment Market by Route of Administration
10.4.5.2.4. Middle East Monkeypox Vaccine and Treatment Market by End-use
10.4.5.3. Africa Monkeypox Vaccine and Treatment Market
10.4.5.3.1. Africa Monkeypox Vaccine and Treatment Market by Product
10.4.5.3.2. Africa Monkeypox Vaccine and Treatment Market by Gender
10.4.5.3.3. Africa Monkeypox Vaccine and Treatment Market by Route of Administration
10.4.5.3.4. Africa Monkeypox Vaccine and Treatment Market by End-use
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security